Wedbush Equities Analysts Lift Earnings Estimates for ORIC
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Equities researchers at Wedbush lifted their Q1 2025 earnings estimates for ORIC Pharmaceuticals in a note issued to investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now anticipates that the company will earn ($0.50) per share for the quarter, up from their previous estimate of ($0.52). […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Equities researchers at Wedbush lifted their Q1 2025 earnings estimates for ORIC Pharmaceuticals in a note issued to investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now anticipates that the company will earn ($0.50) per share for the quarter, up from their previous estimate of ($0.52). […]
